All sponsors

Summit Therapeutics $SMMT

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-35
RECRUITING3
READOUTS ≤12 MONTHS0
Open Summit Therapeutics on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
AK112 Injection
NCT06396065
P3Active, not recruitingNon-Squamous Non-small Cell Lung Cancer4202025-04-12 (-9 mo)
HARMONi-7
NCT06767514
P3RecruitingNon-Small Cell Lung Cancer7802028-04
HARMONi-GI3
NCT07228832
P3RecruitingMetastatic Colorectal Cancer (CRC)9002028-05-31
Ivonescimab Injection
NCT05899608
P3Active, not recruitingNon-Small Cell Lung Cancer16002028-12-31 (+15 mo)
SMT112-216
NCT07877194
P2Not yet recruitingRenal Cell Carcinoma, Clear Cell1002029-04-12
HARMONi-GU1
NCT07815665
P2/3RecruitingMetastatic Urothelial Carcinoma; Metastatic Urothelial Carcinoma (UC)8002030-10-31